Island Pharma aims to turn Galidesivir, its antiviral ace against Marburg, into reality – with the FDA’s November call to ...

October 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), announced that ...

A year ago, Rwanda faced its first outbreak of Marburg virus. Dr. Tsion Firew remembers how scared she was — and how that didn't stop her from playing a key role in the remarkably effective response.

Researchers from UNIGE and Marburg show that D-cysteine, the "mirror" form of cysteine, selectively targets certain cancer ...

I want to tell you about a doctor who was in Rwanda helping patients during the country's first Marburg outbreak. This was one year ago. The virus is a cousin to Ebola. It's nasty and deadly, and more ...

Ebola is one of the nasty viruses that can hide in the body even after a patient recovers and tests negative. It can reemerge and trigger a new outbreak years later. How do they survive? And how can ...

Drug developers have been acquiring complimentary programs to reduce execution risk and maintain investor interest.

Ebola is one of the nasty viruses that can hide in the body even after a patient recovers and tests negative. It can reemerge ...

SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the ...

Tsion Firew had just finished running a first aid training when she glanced down at her phone — and then looked up confused. The message she saw was about a colleague Firew had worked with a few days ...